Key facts
- AMOpportunities’s last known valuation is $25.6M (Jan 2024).
- It has raised $12.1M across 6 recorded rounds; the latest was Seed Round ($1.0M) in Nov 2024.
- Notable investors include AIM Equity Partners, Fidus Capital.
- AMOpportunities has filed 10 Form Ds with the SEC since 2017, most recently Dec 2024 ($1.0M sold to 3 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for AMOpportunities
Funding rounds
6 roundsAbout AMOpportunities
Provider of clinical and research internship programs intended to connect international medical students with clinical training opportunities. The company offers in-person and virtual clinical experiences, facilitating access to training sites, enabling international medical students to gain essential skills and improve their residency match rates, share and discuss medical topics, read case studies, create projects to enhance their knowledge and address the healthcare workforce shortage.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Chicago, IL, United States
- Founded
- 2013
- Employees
- 25
- Website
- amopportunities.org/
- Ownership
- Privately Held (backing)
AMOpportunities doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AMOpportunities shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AMOpportunities in its N-PORT filings yet. We sweep new filings monthly.